All Type of News
Dong-A likely to commercialize new second-generation oxazolidinone antibiotic
Dong-A Pharmaceutical Co. announced Thursday the positive results of its new second-generation oxazolidinone antibiotic (tedizolid phosphate; DA-7218) from the first Phase 3 clinical trial in acute bacterial skin and ...
UCB Korea holds Vimpat symposium
Scores of neurologists and pediatricians at home and abroad gathered in Seoul and Busan between January 13 and 14 to participate in a launching symposium of Vimpat (lacosamide) on the future strategy of epilepsy.
T...
LDLC to forge strategic tie-up with public corporation
The Korea Drug Logistics Cooperative (KDLC) said yesterday that it will forge a strategic alliance with a leading state-run corporation in an effort to construct a mass-scale drug logistic center.
Inaugurating its ...
Government to cut drug prices thoroughly and cruelly
The government plans to slash the price of about half the drugs on the market by an average of 14 percent, the Ministry of Health and Welfare said Wednesday.
In a local forum organized by the National Health Insura...
Revision of pharmaceutical affairs law hits snag
A bill to revise the pharmaceutical affairs law, designed to allow the sale of painkillers and cold medicines at convenience stores, is facing a major obstacle due to negative response of lawmakers.
Both ruling and...
NHIC sees surplus of 600.8 billion won
The National Health Insurance Corp. said Monday that the national health insurance fund was 600.8 billion won in the black last November.
Fund revenue increased by 15 percent due to the 5.9 percent premium raise la...
Pharmacists seeking reclassification of some OTC products
A lawyer for five local pharmacists associations, who filed a suit against the Korea Food and Drug Administration, asked to reclassify ointments and patches among 48 non-prescription remedies as quasi-drugs noticed in...
Daewoong to launch oxybutynin gel in Korea
Daewoong Pharmaceutical announced Wednesday that it signed an exclusive licensing agreement with the U.S. based Antares Pharma to distribute Antares’s topical oxybutynin gel 3% product inn Korea.
Last December, The...
KPA under siege
The executives of the Korean Pharmaceutical Association — under fire for its decision to agree a plan with the health ministry to allow the sale of non-prescription drugs at places other than pharmacies — is moving to...
Layouts of 1,321 OTC ads approved in 2011
The Korea Pharmaceutical Manufacturers Association said yesterday that it screened a total of 1,351 advertisement layouts on OTC drugs in 2011, up 19.3 percent compared with 1,132 layouts in 2010.
Of the 1,351 lay...
